semaglutide and cagrilintide & GLP-1 S The next frontier in metabolic

We recorded the number of rats that maintained the initial position of firmly standing on the surface with posterior legs, with only limited movements around, as well as the number of those demonstrating no freezing behavior, quick exploration, and escaping from the elevated surface

Observed benefits of MBS extended beyond glycaemic control and weight loss

[DOI] [PubMed] [Google Scholar] 7.Baydas G, Tuzcu M

So maybe this is not a concern

Retatrutide's triple receptor activity produces larger total weight reduction in clinical trials (~24-29% vs ~20-22% for tirzepatide), but the side effect profile is more demanding during titration